Pharmaceuticals

Pimozide Tablet Market Future Outlook: Strong Growth Expected Toward $2.91 Billion by 2030

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pimozide tablet market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Pimozide Tablet Market covering 2026–2035?

The pimozide tablet market size has shown robust growth over recent years. It is anticipated to expand from $1.84 billion in 2025 to $2.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. This past growth can be ascribed to several factors, including restricted treatment alternatives for Tourette’s syndrome, an increasing prevalence of chronic schizophrenia, improvements in hospital and clinic infrastructure, heightened awareness of antipsychotic therapies, and a continued reliance on traditional offline pharmacies.

The pimozide tablet market is anticipated to experience substantial expansion in the coming years. Projections indicate its value will reach $2.91 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.5%. This projected growth is primarily driven by factors such as the introduction of low-dose and unit-dose pimozide tablets, the proliferation of online pharmacy platforms, an uptick in home healthcare adoption, escalating government efforts in mental health, and the incorporation of digital tools for adherence monitoring. Key trends anticipated during this period encompass heightened awareness of Tourette’s Syndrome and chronic schizophrenia, a growing inclination towards oral antipsychotic medications, the expansion of home-based mental health care and therapy services, the broadening of online pharmaceutical distribution networks, and the creation of customized dosing and packaging solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19655&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Pimozide Tablet Market?

An increasing occurrence of psychiatric disorders is anticipated to drive the expansion of the pimozide tablet market in the future. These disorders encompass mental health issues marked by considerable disruptions in an individual’s thoughts, feelings, or actions, which can result in emotional distress or compromised daily functioning. The growing incidence of psychiatric disorders is mainly linked to elements like heightened stress, evolving societal conventions, enhanced understanding and identification, and genetic susceptibilities. Pimozide tablets serve in psychiatric treatment to control manifestations like delusions and tics by inhibiting dopamine receptors, which helps in mitigating irregular brain activity. For example, the Substance Abuse and Mental Health Services Administration (SAMHSA), a US federal agency, stated in August 2025 that 23.4% of adults aged 18 or above (approximately 61.5 million individuals) had experienced any mental illness (AMI), and around 5.6 % indicated a serious mental illness (SMI). In contrast, 22.8 % (58.7 million people) and 5.7 % (14.6 million people) of adults reported AMI and SMI, respectively, in 2023. Consequently, the increasing prevalence of psychiatric disorders is a key factor propelling the pimozide tablet market.

What Leading Segments Are Studied In The Pimozide Tablet Market?

The pimozide tablet market covered in this report is segmented –

1) By Type: 1 Milligram, 2 Milligram, 4 Milligram

2) By Distribution Channel: Online, Offline

3) By Application: Tourette’s Syndrome, Chronic Schizophrenia

4) By End User: Hospitals, Clinics, Home Use

Which Key Market Players Are Investing In Expansion And Innovation Within The Pimozide Tablet Market?

Major companies operating in the pimozide tablet market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bristol-Myers Squibb, GlaxoSmithKline plc, C.H. Boehringer Sohn AG & Co. KG, Teva Pharmaceutical Industries Ltd., Hetero Drugs, Sun Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, Aurobindo Pharma, Cipla Limited, Apotex Inc., H. Lundbeck A/S, Dr. Reddy’s Laboratories, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Endo International, Lupin Limited, Zydus Cadila, Alkem Laboratories, Torrent Pharmaceuticals, Glenmark Pharmaceuticals, Mallinckrodt Pharmaceuticals, Jubilant Life Sciences, Alembic Pharmaceuticals, Wockhardt, AA Pharma, Taj Pharmaceuticals

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pimozide-tablet-global-market-report

Which Regions Are Poised For Strategic Growth In The Pimozide Tablet Market?

North America was the largest region in the pimozide tablet market in 2025. The regions covered in the pimozide tablet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pimozide Tablet Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19655&type=smp

Browse Through More Reports Similar to the Global Pimozide Tablet Market 2026, By The Business Research Company

Smart Phone Tablet Games Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-phone-tablet-games-global-market-report

Tablets Market Report 2026

https://www.thebusinessresearchcompany.com/report/tablets-global-market-report

Multivitamin Capsules And Tablets Market Report 2026

https://www.thebusinessresearchcompany.com/report/multivitamin-capsules-and-tablets-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795